Omni Health Announced Launch of Consumer Goods Division; New Division Anticipated Revenue of $7mln in 2018

MIAMI, FL, Dec. 12, 2017 -- Omni Health, Inc., (OTC: OMHE), a vertically integrated healthcare company dedicated to the development of pharmaceutical, anti-aging products, and biotech engineering, today announced the launch of its newly-created Consumer Products division commencing with first order from a major US catalog house.

Omni Health’s Consumer Goods Division will be operating via a subsidiary, Celebrity Brands Inc. Celebrity Brands will bring an entirely new reach to Omni Health’s operations with a new set of investment priorities and a sharpened set of portfolio choices to accelerate growth and performance. The company will also focus on strengthening its portfolio by acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands. The Company anticipates this new division to bring a gross revenue of over $7mln in 2018 with a very high margin EBIDTA.

Celebrity Brands’ first wholesale order is from Amerimark Direct for Celeb Cream – one of the Company’s innovative anti-aging products. Amerimark Direct is one of US largest mail order and direct marketing companies operating ten catalogs and seven websites and specializing in cosmetics, diet and weight loss, personal care products, and As Seen on TV products, among others.

“Omni Health’s new strategic plan establishes a clear set of investment priorities, and the ability to capitalize on company’s four decades of exemplary healthcare by becoming a major force in manufacturing and distributing high-margin anti-aging and CBD consumer brands with the greatest potential for growth and value creation,” said Andrey Soloviev, Omni Health Chief Executive Officer. “We will drive growth acceleration through more effective and scaled commercial operations, increased investment in our brands and capabilities, and the delivery of bigger and better innovation across a broader set of categories.”

With this exciting development, Omni Health intends to become a first mainstream force in the development and introduction to market of innovative CBD and anti-aging consumer products through long-term retail partnerships, high-profile celebrity endorsements, and cross branding.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.

Contact:

Andrey Soloviev

CEO

[email protected]